Office-Based Asthma Screening Intervention
Primary Purpose
Asthma
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Provider Prompt
Sponsored by

About this trial
This is an interventional prevention trial for Asthma
Eligibility Criteria
Inclusion Criteria: Children ages 2-12 Children arriving for an office visit in two Rochester, NY pediatric clinics Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years Exclusion Criteria: Children arriving at the office visit with an adult that is not their parent or guardian Children arriving at the office visit with a parent or guardian that does not speak English Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)
Sites / Locations
- University of Rochester
Outcomes
Primary Outcome Measures
"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
Secondary Outcome Measures
Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.
Full Information
NCT ID
NCT00156468
First Posted
September 8, 2005
Last Updated
May 11, 2011
Sponsor
University of Rochester
Collaborators
Halcyon Hill Foundation, Robert Wood Johnson Foundation
1. Study Identification
Unique Protocol Identification Number
NCT00156468
Brief Title
Office-Based Asthma Screening Intervention
Official Title
Office-Based Asthma Screening Intervention
Study Type
Interventional
2. Study Status
Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
October 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
September 2005 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University of Rochester
Collaborators
Halcyon Hill Foundation, Robert Wood Johnson Foundation
4. Oversight
5. Study Description
Brief Summary
In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
Enrollment
365 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Provider Prompt
Primary Outcome Measure Information:
Title
"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
Secondary Outcome Measure Information:
Title
Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children ages 2-12
Children arriving for an office visit in two Rochester, NY pediatric clinics
Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years
Exclusion Criteria:
Children arriving at the office visit with an adult that is not their parent or guardian
Children arriving at the office visit with a parent or guardian that does not speak English
Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jill S Halterman, MD, MPH
Organizational Affiliation
University of Rochester
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Rochester
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
16939999
Citation
Halterman JS, Kitzman H, McMullen A, Lynch K, Fagnano M, Conn KM, Yoos HL. Quantifying preventive asthma care delivered at office visits: the Preventive Asthma Care-Composite Index (PAC-CI). J Asthma. 2006 Sep;43(7):559-64. doi: 10.1080/02770900600859172.
Results Reference
background
PubMed Identifier
16530150
Citation
Halterman JS, Fagnano M, Conn KM, Szilagyi PG. Do parents of urban children with persistent asthma ban smoking in their homes and cars? Ambul Pediatr. 2006 Mar-Apr;6(2):115-9. doi: 10.1016/j.ambp.2005.10.004.
Results Reference
background
PubMed Identifier
17018460
Citation
Halterman JS, Fisher S, Conn KM, Fagnano M, Lynch K, Marky A, Szilagyi PG. Improved preventive care for asthma: a randomized trial of clinician prompting in pediatric offices. Arch Pediatr Adolesc Med. 2006 Oct;160(10):1018-25. doi: 10.1001/archpedi.160.10.1018.
Results Reference
result
Learn more about this trial
Office-Based Asthma Screening Intervention
We'll reach out to this number within 24 hrs